Initial Institutional Experience With Cryoablation Therapy for Breast Fibroadenomas: Technique, Molecular Science, and Post-Therapy Imaging Follow-up.
ablation
breast
cryoablation
fibroadenoma
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
17
09
2018
revised:
04
12
2018
accepted:
22
12
2018
pubmed:
8
3
2019
medline:
10
3
2020
entrez:
8
3
2019
Statut:
ppublish
Résumé
Cryoablation is a safe and effective nonsurgical treatment for breast fibroadenomas (FAs). The treatment response is inversely related to the tumor size, with lesions less than 2 cm showing an optimal response. Ultrasound (US) imaging follow-up of the ablated tumor is recommended at 6-month intervals for 2 years at our institution. Although a decrease in the size of the FA clinically and on US imaging is the expected treatment response, variations can be seen. Knowledge of typical US changes over time is imperative to prevent unnecessary rebiopsy or excision in patients who have undergone cryoablation. We will review the initial patient selection criteria, cryoablation technique, and US findings at regular follow-up intervals after cryoablation of FAs through a series of cases treated at our institution.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2769-2776Informations de copyright
© 2019 by the American Institute of Ultrasound in Medicine.
Références
Tomkovich KR. Interventional radiology in the diagnosis and treatment of diseases of the breast: a historical review and future perspective based on currently available techniques. AJR Am J Roentgenol 2014; 203:725-733.
Sag AA, Maybody M, Comstock C, Solomon SB. Percutaneous image-guided ablation of breast tumors: an overview. Semin Intervent Radiol 2014; 31:193-202.
Kaufman CS, Littrup PJ, Freeman-Gibb LA, et al. Office-based cryoablation of breast fibroadenomas with long-term follow-up. Breast J 2005; 11:344-350.
Kaufman CS, Bachman B, Littrup PJ, et al. Cryoablation treatment of benign breast lesions with 12-month follow-up. Am J Surg 2004; 188:340-348.
Edwards MJ, Broadwater R, Tafra L, et al. Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice. Am J Surg 2004; 188:221-224.
Caleffi M, Filho DD, Borghetti K, et al. Cryoablation of benign breast tumors: evolution of technique and technology. Breast 2004; 13:397-407.
Golatta M, Harcos A, Pavlista D, et al. Ultrasound-guided cryoablation of breast fibroadenoma: a pilot trial. Arch Gynecol Obstet 2015; 291:1355-1360.
Littrup PJ, Freeman-Gibb L, Andea A, et al. Cryotherapy for breast fibroadenomas. Radiology 2005; 234:63-72.
Nurko J, Mabry CD, Whitworth P, et al. Interim results from the FibroAdenoma Cryoablation Treatment Registry. Am J Surg 2005; 190:647-652.
Hahn M, Pavlista D, Danes J, et al. Ultrasound guided cryoablation of fibroadenomas. Ultraschall Med 2013; 34:64-68.
Kaufman CS, Bachman B, Littrup PJ, et al. Office-based ultrasound-guided cryoablation of breast fibroadenomas. Am J Surg 2002; 184:394-400.
Feldman M, Katyal S, Blackwood M. Ultrasound artifacts. Radiographics 2009; 29:1179-1189.
de Waele ATAM. Basics of Joule-Thomson liquefaction and JT cooling. J Low Temp Phys 2017; 186:385-340.
Whitworth PW, Rewcastle JC. Cryoablation and cryolocalization in the management of breast disease. J Surg Oncol 2005; 90:1-9.
Baust JG, Gage A. The molecular basis of cryosurgery. BJU Int 2005; 95:1187-1191.
Fine RE, Whitworth PW, Kim JA, et al. Low-risk palpable breast masses removed using a vacuum-assisted hand-held device. Am J Surg 2003; 186:362-367.